also associated with a wide range of systemic pathologies, including cardiovascular disease. 5, 6 Smoking has been found to adversely affect neutrophil function, for instance, cigarette smoke extract (CSE) was shown to promote neutrophil degranulation, which may cause an exaggerated response to invading bacteria and induce local tissue damage. 7 We have reported previously that CSE can perturb neutrophil reactive oxygen species (ROS) production 8, 9 and it is possible that exposure to cigarette smoke (CS)-derived chemicals impair neutrophil responses to periodontal bacteria if ROS species are not being generated appropriately.
CS is estimated to consist of more than 7000 different chemical compounds. 10 The first widely accepted tobacco biomarkers as indicators of exposure were salivary and serum thiocyanate (SCN-) as well as nicotine and its metabolite cotinine, and they have remained in use for exposure studies until today. SCN-is the metabolite of hydrogen cyanate, which is present in CS in concentrations exceeding those approved by the US Food and Drug Administration. Nicotine is present in high concentrations in CS relative to other CS components, thus leading to medically significant systemic cotinine levels. 10, 11 In addition to the previously reported altered neutrophil ROS responses to CSE, 8, 9 changes in chemotaxis and formation of neutrophil extracellular traps (NETs), may also represent a mechanistic link between smoking and periodontitis. Moreover, the production of NETs, which possess antimicrobial as well as pro-and auto-inflammatory properties, may also be perturbed by CS due to their dependence on ROS generation. 12 However, to date, there are no published data on the direct effects of CSE on NET formation. Therefore, this study was conducted to understand better the impact of CSE, nicotine, cotinine and SCN-upon NET release, expression of inflammatory response-related genes as well as on chemotaxis.
| MATERIAL AND ME THODS

| Neutrophil isolation
Neutrophils were isolated from the peripheral venous blood of periodontally and systemically healthy non-smoking volunteers (University of Birmingham Ethics Reference: ERN_13-0325) using discontinuous Percoll gradients (GE Healthcare, Amersham, UK) as previously described. 13, 14 Cell viability and purity were confirmed by trypan blue exclusion and flow cytometry, respectively, and was typically >98%.
| Extraction and preparation of cigarette smoke extract
CSE was extracted and prepared as previously described. 8 In brief, CSE was collected by drawing CS through filters and bubbled through phosphate-buffered saline (PBS). The resultant extract represented 83.6 μg/mL of nicotine and was stored in liquid nitrogen until further use. Reported levels of nicotine in saliva and gingival crevicular fluid after smoking 1 cigarette are 1.82 ± 0.61 and 5.96 ± 0.77 μg/mL, respectively (mean ± SE). 15 CSE was diluted with PBS to final concentrations of 1%, 5% and 10%, which is equivalent to 0.84, 4.2 and 8.4 μg/mL of nicotine, respectively. Notably, neutrophils enter the oral cavity through the gingival crevice and are thus exposed to the CS component/metabolite concentrations found in gingival crevicular fluid and saliva. Nicotine, cotinine and SCN-were obtained from Sigma-Aldrich (Dorset, UK).
| Thiocyanate levels in cigarette smoke extract
SCN-was assessed by colorimetric quantification of the red coloured complex ion formed by Fe(III) chloride (Sigma-Aldrich).
| Quantification and visual assessment of neutrophil extracellular trap-DNA
Quantification of NET-DNA was performed as described previously. 
| Assessment of neutrophil apoptosis
Neutrophil apoptosis in response to CSE, nicotine, cotinine or SCNwas measured by determining caspase-3 and -7 activity using the Caspase-Glo ® 3/7 assay (Promega, Southampton, UK) according to the manufacturer's instructions. In addition, neutrophil adenosine triphosphate production was measured by chemiluminescence (Berthold Tristar2 plate reader, Harpenden, UK) using CellTiter-Glo ® (Promega) according to the manufacturer's instructions. The amount of adenosine triphosphate measured is indicative of neutrophil metabolic activity and therefore proportional to the number of viable cells. 16 
| Neutrophil chemotaxis assay
Chemotaxis assays were conducted as previously described 17 using the Insall chamber. 18 To determine the effect of CSE on neutrophil chemotaxis, neutrophil migration of 5 different donors was assessed.
Isolated neutrophils were pre-incubated with PBS (negative control) or CSE (1%, 5% and 10%) for 30 minutes and then washed 3 times with RPMI. Chemoattractants were N-formyl-methionyl-leucylphenylalanine (fMLP, 10 nm) and interleukin-8 (IL-8, 200 ng/mL) (both from Sigma-Aldrich) and RPMI medium alone served as a negative control. Reference genes
Target genes Target genes NFKBIE (nuclear factor-kappa-B inhibitor epsilon)
were considered statistically significant. One-way ANOVA and Dunnett's post-hoc tests were used for NET quantification and viability assays, where different parameters were compared with a control. One-way ANOVA and Bonferroni post-hoc tests were used for chemotaxis and PCR data, where pairwise comparisons were applied.
| RE SULTS
| Thiocyanate is not present in cigarette smoke extract
Cotinine is known to be both a metabolite of nicotine and a component of tobacco leaves. 24 While SCN-is a metabolite generated in the liver from hydrogen cyanide present in CS, 25 there are no reports regarding the possible presence of SCN-in CS or tobacco products.
Although many plants are thought to generate SCN-, 26 we found no detectable SCN-in our CSE, as the measured concentrations were below the lower limit of detection of <10 nm. This suggests that SCNis generated within the host after CS ingestion only.
| Effect of cigarette smoke extract, nicotine, cotinine and thiocyanate on neutrophil extracellular trap release in the absence of subsequent stimulation
The effect of CSE (at concentrations of 1%, 5% or 10%) on NET release did not differ significantly from PBS-treated cells (negative control) (P = .99, Figure 1-1A) . Similarly, nicotine and cotinine treatment 10% CSE resulted in a significantly decreased speed of neutrophil migration in response to fMLP (P < .001, Figure 2C ). Migration speed in response to IL-8 (10 nm) following 10% CSE treatment was significantly lower than that of PBS controls (P < .001, Figure 2D ).
Velocity of neutrophil migration was significantly decreased in response to fMLP and IL-8 following treatment with 1%, 5% and 10%
CSE, compared with those treated with PBS ( Figure 2E,F) . Notably, the speed and velocity of 10% CSE-treated neutrophils in response to fMLP and IL-8 were not significantly different from cells moving in response to the negative control (RPMI). Accordingly, 5% and 10% of CSE caused significant decreases in resultant vector length , 1%, 5% or 10%) in response to fMLP (E) or IL-8 (F) or the negative control (RPMI). Statistical significance was calculated using 1-way ANOVA and Bonferroni post hoc testing (*P < .05, **P < .01, ***P < .001, ****P < .0001, n.s.). Data were calculated from the tracking of 15 cells (n = 5) and are expressed as box and whisker plots (minimum to maximum with median, first and third quartile; blue crosses show the mean values). CSE, cigarette smoke extract; fMLP, N-formyl-methionyl-leucyl-phenylalanine; IL, interleukin; n.s., not significant; PBS, phosphate-buffered saline
| D ISCUSS I ON
To the best of our knowledge, this is the first study to investigate the effects of CSE, nicotine, cotinine and SCN-on ex vivo neu- 
28,29
However, stable levels of the nicotine metabolite cotinine in saliva and serum of individuals smoking up to 50 cigarettes are <700 ng/ mL, 30 thus the concentrations used in these studies may not be applicable to in vivo conditions. The data presented here, together with our previously published reports showing that nicotine and cotinine have no effect on the neutrophil respiratory burst, 8, 9 suggest that these 2 CS components do not affect neutrophil function when applied in physiologically relevant concentrations, and that CSE alone is not a NET trigger.
CSE exhibited differential effects upon ex vivo stimulated NET release, with CSE pre-treatment inhibiting PMA-induced NET production, but having no effect on HOCl-induced NET formation.
Two reports demonstrated that CSE inhibits PMA-induced neutrophil ROS production, 15, 31 being in accordance with the findings of our study. PMA is a potent agonist for protein kinase C (PKC), which triggers neutrophil NADPH-oxidase activation, subsequent ROS production and ROS-dependent NET release. It is recognized that smoke exposure can perturb PKC signalling and therefore influence cell inflammatory responses. 32, 33 Reduced neutrophil total and extracellular ROS and superoxide formation following CSE pretreatment have been observed in response to a variety of stimuli including the periodontal pathogen Fusobacterium nucleatum. 8, 9 This suggests that smoking may subvert the successful elimination of periodontal bacteria by neutrophils.
No differences in HOCl-induced NET production following CSE pre-treatment were detected in this study, supporting a mechanism involving perturbed PKC signalling, as unlike PMA, HOCl activates neutrophil NET formation downstream of PKC. 12 Notably, the current data demonstrate that the inhibitory effects of CSE on neutrophil DNA/NET release are not due to cytotoxic effects, as neutrophil viability was demonstrated by trypan blue dye exclusion. This is in accordance with our previous studies demonstrating that neutrophil viability was not affected by CSE (1%-100%), nicotine (1-10 mg/mL) or cotinine (1-10 mg/mL). 8 Thus, in future studies, those compounds of CSE, which are responsible for the inhibition of PKC-mediated NET release, need to be unravelled in comprehensive screening assays. They should involve all classes of chemicals present in CS as well as in the host after metabolic breakdown of these chemicals, such as aldehydes, phenols, amines and N-nitrosamines, heavy metals and hydrocarbons.
10
Salivary SCN-is implicated in the delayed wound healing observed in smokers. 34 SCN-pre-treatment reduced PMA-and HOClinduced NET production, but resulted in a concentration-dependent increase in otherwise unstimulated NET release. SCN-is the preferred substrate of neutrophil myeloperoxidase, which catalyses a reaction resulting in the formation of either hypothiocyanous acid (HOSCN) or homocitrulline, a citrulline homologue. 35 As citrullination of the nuclear DNA is a crucial step for NET formation, the generation of homocitrulline could be a possible way by which SCN-directly induces NET release. 36 The reaction of SCN-and myeloperoxidase can thus also inhibit PMA-induced NET release, as it occurs downstream of PKC signalling. 37 HOSCN, on the other hand, selectively reacts with thiols such as glutathione, 38 and thus causes increased depletion of antioxidant thiols. Interestingly, increases in HOSCN, following a switch from HOCl production induced by increased SCN-, are believed to afford protection against HOCl-mediated tissue damage. 39 To benefit from increased levels of HOSCN, it is believed that adequate thiol repair systems are re- is expressed as a ratio to the reference gene, YWHAZ, and RNA expression in cells treated with phosphate-buffered saline (unstimulated negative control) is normalized to 1. Statistical significance was calculated using 1-way ANOVA and Bonferroni post hoc testing (****P < .0001). Data are shown as mean ± SD (n = 10 pooled biological repeats and n = 3 technical repeats in triplicate). CSE, cigarette smoke extract; SCN-, thiocyanate
are not in the direction of the chemoattractant. 42, 43 higher in saliva than in blood after smoking. 49, 50 Thus, future studies may be directed at investigating the effect of low-level circulating CS components on neutrophil priming. Interestingly, CS-derived compounds may also be degraded more rapidly in the oral cavity in the presence of specific bacterial strains, 51 Smoking frequently leads to the onset and progression of severe forms of periodontitis. 55 In 2015, over 1.1 billion people smoked tobacco worldwide and while this number is declining in many countries, the prevalence of tobacco smoking appears to be increasing in some other regions. 56 Thus, smoking remains a relevant risk factor for oral and systemic diseases. The data presented here, despite the limita- 
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